CAS 17352-25-9

3,5-diiodobenzaldehyde

Codes: ANAC-042

Application context (from source-drug indications)

HypercholesterolaemiaAnacetrapibCardiac and vascular disordersAnacetrapibDyslipidaemiaAnacetrapibAtherosclerosisAnacetrapibHyperlipoproteinaemia type IIAnacetrapibHomozygous familial hypercholesterolaemiaAnacetrapib

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Anacetrapib	Tier C — Watch / trade	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

AnacetrapibOptimised routesteps: 4total yield: 85.00 mg

(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyloxazolidin-2-one→nitroethane→2'-(chloromethyl)-4-fluoro-5-isopropyl-2-methoxy-4'-(trifluoromethyl)-1,1'-biphenyl→3,5-diiodobenzaldehyde→(1R,2S)-1-(3,5-diiodophenyl)-2-nitropropan-1-ol→(4S,5R)-5-(3,5-diiodophenyl)-4-methyloxazolidin-2-one

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.